ストックスクリーナーアプリを入手
0.33
9.38%
0.0283
プレマーケット:
.35
0.02
+6.06%
前日終値:
$0.3017
開ける：
$0.302
24時間の取引高:
1.33M
Relative Volume:
3.08
時価総額：
$26.79M
収益：
$3.38M
当期純損益:
$-15.06M
株価収益率:
-1.4072
EPS:
-0.2345
ネットキャッシュフロー:
$-15.50M
1週間 パフォーマンス:
+9.63%
1か月 パフォーマンス:
-47.62%
6か月 パフォーマンス:
-67.00%
1年 パフォーマンス:
-70.27%
1日の値動き範囲:
$0.3011
$0.37
1週間の範囲:
$0.2805
$0.37
52週間の値動き範囲:
$0.2771
$1.40
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.33 | 26.79M | 3.38M | -15.06M | -15.50M | -0.2345 |
ABT
Abbott Laboratories
|
101.83 | 176.95B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.07 | 127.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.42 | 110.95B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
61.86 | 91.93B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.84 | 46.61B | 6.07B | 1.06B | 1.34B | 1.8063 |
Icecure Medical Ltd (ICCM) 最新ニュース
Market Wrap: Should I set a stop loss on IceCure Medical Ltd2026 Short Interest & Real-Time Buy Signal Notifications - baoquankhu1.vn
Is IceCure Medical Ltd a stock for growth or value investors2026 Drop Watch & AI Enhanced Execution Alerts - baoquankhu1.vn
Why Is IceCure Medical Ltd (ICCM) Stock Down Today? - Meyka
Day Trade: Is IceCure Medical Ltd subject to activist investor interest - baoquankhu1.vn
IceCure Medical (NASDAQ: ICCM) resale filing covers 16M shares, warrants exercisable - Stock Titan
ICCM Technical Analysis & Stock Price Forecast - Intellectia AI
ICCM PE Ratio & Valuation, Is ICCM Overvalued - Intellectia AI
Fund Flows: Should I set a stop loss on IceCure Medical LtdShort Setup & Verified Trade Idea Suggestions - baoquankhu1.vn
IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates - MSN
ICCM SEC FilingsIcecure Medical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
IceCure Medical Appoints New CFO and Medical Director - Intellectia AI
IceCure (NASDAQ: ICCM) offers 8M shares with 16M private warrants - Stock Titan
Epoch updates 45.8% IceCure Medical (ICCM) stake and board change - Stock Titan
IceCure Medical (ICCM) prices $4M share sale with concurrent warrants - Stock Titan
IceCure prices $4M direct offering, concurrent private placement - MSN
IceCure Announces Pricing of $4.0 Million Registered Direct Offe - GuruFocus
IceCure Medical (ICCM) Secures $4M Through Direct Offering - GuruFocus
IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement (2026-03-26) - Seeking Alpha
IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement - Finansavisen
[Form 3] IceCure Medical Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Huang Yang reports RSUs and options in IceCure Medical (NASDAQ: ICCM) - stocktitan.net
IceCure Medical (NASDAQ: ICCM) director Chan Vincent Chun Hung files Form 3 - Stock Titan
IceCure Medical (ICCM) VP discloses shares, RSUs and option grants - Stock Titan
IceCure Medical (ICCM) COO discloses share, option and RSU stakes - Stock Titan
IceCure Medical (ICCM) VP details RSUs and stock option grants - Stock Titan
IceCure Medical (ICCM) CFO details shares, RSUs and options in Form 3 - Stock Titan
IceCure Medical (ICCM) director discloses shares and options in Form 3 - Stock Titan
IceCure Medical (ICCM) VP Naum Muchnik details insider share and option holdings - Stock Titan
IceCure Medical (ICCM) VP details share, option and RSU holdings - Stock Titan
IceCure Medical (ICCM) CEO details share, RSU and option stakes - Stock Titan
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates - Bitget
IceCure Medical Posts Strong 5-Year Kidney Cancer Cryoablation Data From ICESECRET Trial - TipRanks
IceCure Medical Ltd Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study - MarketScreener
IceCure Medical (ICCM) Reports Positive Outcomes in Kidney Cance - GuruFocus
IceCure Medical (Nasdaq: ICCM) unveils 5-year kidney cancer data - Stock Titan
IceCure names Meir Peleg as CFO - Medical Buyer
[EFFECT] IceCure Medical Ltd. SEC Filing - Stock Titan
IceCure Medical Names New CFO and Plans Key Leadership Changes Amid ProSense® Growth - tipranks.com
IceCure Appoints Meir Peleg as Chief Financial Officer - GuruFocus
IceCure Medical (NASDAQ: ICCM) hires Meir Peleg as new CFO - Stock Titan
[EFFECT] IceCure Medical Ltd.... | ICCM SEC FilingForm EFFECT - Stock Titan
Dip Buying: Is IceCure Medical Ltd subject to activist investor interest2026 Selloffs & Precise Buy Zone Identification - baoquankhu1.vn
Published on: 2026-03-22 01:37:56 - baoquankhu1.vn
Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic U.S. ... By GuruFocus - Investing.com Canada
Ideas Watch: What dividend growth rate does IceCure Medical Ltd offerM&A Rumor & Breakout Confirmation Trade Signals - baoquankhu1.vn
Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Rec - GuruFocus
IceCure Medical (NASDAQ: ICCM) registers $100M shelf for shares and warrants - Stock Titan
IceCure Medical (NASDAQ: ICCM) registers 9.74M shares from outstanding warrants - Stock Titan
History Review: Is IceCure Medical Ltd stock a good dividend stock2026 Volume & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 earnings call transcript - MSN
IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript - insidermonkey.com
Icecure Medical Ltd (ICCM) 財務データ
収益
当期純利益
現金流量
EPS
0.44%
0.34%
大文字化:
|
ボリューム (24 時間):